# Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume

> **NCT04682691** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 50 (actual)

## Conditions studied

- Gastric Residual Volume

## Interventions

- **DRUG:** Erythromycin (400mg)
- **DRUG:** metoclopramide (10mg)
- **DIETARY_SUPPLEMENT:** naturally flavored water

## Key facts

- **NCT ID:** NCT04682691
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2024-02-05
- **Final completion:** 2024-02-22
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682691, "Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04682691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*